2026 Annual Meeting | C105 - Interpreting Lumbar Puncture Findings: A Case-based Evaluation
| 01:00 PM - 01:05 PM CDT | Introduction |
Interpreting Lumbar Puncture Findings: A Case-based Evaluation
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
| 01:05 PM - 01:35 PM CDT | Speaker |
Case-based Approach to CSF Findings in Neuroinflammation
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
| 01:35 PM - 01:40 PM CDT | Q&A |
Questions and Answers
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
| 01:40 PM - 02:15 PM CDT | Speaker |
CSF Findings in Neurodegenerative Conditions
Gregory S. Day, MD, MSc, FAAN |
| 02:15 PM - 02:20 PM CDT | Q&A |
Questions and Answers
Gregory S. Day, MD, MSc, FAAN |
| 02:20 PM - 02:50 PM CDT | Speaker |
CSF Dynamics: Interpretations in Clinical Practice
Olga Fermo, MD |
| 02:50 PM - 02:55 PM CDT | Q&A |
Questions and Answers
Olga Fermo, MD |
| 02:55 PM - 03:00 PM CDT | Closing Remarks |
Summary
Sarosh R. Irani, MD, PhD, FRCP, FEAN |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN | Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AZ, Roche, Cerebral therapeutics, Biogen, Amgen, Argenex, Clarivate, IQVIA, BioHaven therapeutics.. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Olga Fermo, MD | Dr. Fermo has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier . |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |